Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging
Phase 2
Not yet recruiting
- Conditions
- Refractory Dermatomyostitis
- Registration Number
- NCT06568783
- Lead Sponsor
- Farshad Moradi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Inclusion Criteria:<br><br> 1. Patients with suspected dermatomyositis.<br><br> 2. Patient must be > 18 years old.<br><br> 3. Be willing and able to provide written informed consent for the trial.<br><br>Exclusion Criteria:<br><br> 1. Women who are pregnant or potentially pregnant per the Department of Radiology<br> Policy on Imaging in Potentially Pregnant and Pregnant Women.<br><br> 2. Contraindication to MRI or inability to lie flat for 30 min<br><br> 3. Any serious medical condition that in the opinion of principal investigator could<br> pose significant risk of harm or injury to the patient if they participate in the<br> study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of [18F]-FAPI-74 uptake.
- Secondary Outcome Measures
Name Time Method